These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 2840579)
21. Effects of met-enkephalin on GABAergic spontaneous miniature IPSPs in organotypic slice cultures of the rat hippocampus. Rekling JC J Neurosci; 1993 May; 13(5):1954-64. PubMed ID: 8478686 [TBL] [Abstract][Full Text] [Related]
22. Differential interactions of cholecystokinin and FLFQPQRF-NH2 with mu and delta opioid antinociception in the rat spinal cord. Magnuson DS; Sullivan AF; Simonnet G; Roques BP; Dickenson AH Neuropeptides; 1990 Aug; 16(4):213-8. PubMed ID: 2177165 [TBL] [Abstract][Full Text] [Related]
23. Hypothalamic opioid mu-receptors regulate discrete hemodynamic functions in the conscious rat. Sirén AL; Feuerstein G Neuropharmacology; 1991 Feb; 30(2):143-52. PubMed ID: 1851544 [TBL] [Abstract][Full Text] [Related]
24. Interactions between the effects of opioid, serotonin and alpha-2-adrenergic receptor agonists on growth hormone release in the male rat. Intrahypothalamic administration. Chapman IM; Kapoor R; Willoughby JO Neuroendocrinology; 1993 May; 57(5):921-7. PubMed ID: 8105398 [TBL] [Abstract][Full Text] [Related]
25. An in vitro study on the hippocampal epileptogenic properties of enkephalins and enkephalinase inhibitors in rats. Scotti De Carolis A; Sagratella S; Frank C; Trampus M; Proietti ML Gen Pharmacol; 1991; 22(4):651-7. PubMed ID: 1657689 [TBL] [Abstract][Full Text] [Related]
26. Phosphorylated mu-opioid receptor purified from rat brains lacks functional coupling with Gi1, a GTP-binding protein in reconstituted lipid vesicles. Harada H; Ueda H; Katada T; Ui M; Satoh M Neurosci Lett; 1990 May; 113(1):47-9. PubMed ID: 2164175 [TBL] [Abstract][Full Text] [Related]
27. The influence of an enkephalin derivative, DAGO, on the behavior and activity of neurons of the neocortex and hippocampus of rabbits during the development of defensive and inhibitory conditioned reflexes. Shul'gina GI; Okhotnikov NV; Ryzhov SO; Cherdakova MV Neurosci Behav Physiol; 1990; 20(2):156-66. PubMed ID: 2164170 [TBL] [Abstract][Full Text] [Related]
28. Effect of opioid peptides on the paraventricular nucleus of the guinea pig hypothalamus is mediated by mu-type receptors. Wuarin JP; Dubois-Dauphin M; Raggenbass M; Dreifuss JJ Brain Res; 1988 Apr; 445(2):289-96. PubMed ID: 2836024 [TBL] [Abstract][Full Text] [Related]
29. mu-Opioid receptor activation decreases N-type Ca2+ current in magnocellular neurons of the rat basal forebrain. Soldo BL; Moises HC Brain Res; 1997 May; 758(1-2):118-26. PubMed ID: 9203540 [TBL] [Abstract][Full Text] [Related]
30. mu-Opioid receptors in NTS elicit pressor responses via sympathetic pathways. Hassen AH; Feuerstein G Am J Physiol; 1987 Jan; 252(1 Pt 2):H156-62. PubMed ID: 3028161 [TBL] [Abstract][Full Text] [Related]
31. Modulation of glycine-induced chloride current in acutely dissociated rat periaqueductal gray neurons by mu-opioid agonist DAGO. Min BI; Kim CJ; Rhee JS; Akaike N Brain Res; 1996 Sep; 734(1-2):72-8. PubMed ID: 8896810 [TBL] [Abstract][Full Text] [Related]
32. Effects of diethylstilbestrol on mouse hippocampal evoked potentials in vitro. SanMartín S; Gutiérrez M; Menéndez L; Hidalgo A; Baamonde A Cell Mol Neurobiol; 1999 Dec; 19(6):691-703. PubMed ID: 10456231 [TBL] [Abstract][Full Text] [Related]
33. 8-Bromo-cAMP blocks opioid activation of a voltage-gated potassium current in isolated hippocampal neurons. Wimpey TL; Chavkin C Neurosci Lett; 1992 Mar; 137(1):137-40. PubMed ID: 1320750 [TBL] [Abstract][Full Text] [Related]
34. Further studies on the suppression of luteinizing hormone release due to activation of medial preoptic-anterior hypothalamic area mu-opioid receptors. Smith MJ; Gallo RV Brain Res Bull; 1997; 42(1):1-7. PubMed ID: 8978929 [TBL] [Abstract][Full Text] [Related]
35. Involvement of mu-receptors in the opioid-induced generation of bursting discharges in hippocampal pyramidal cells. Gähwiler BH; Maurer R Regul Pept; 1981 May; 2(2):91-6. PubMed ID: 6265981 [TBL] [Abstract][Full Text] [Related]
36. Effects of DAGO on the rodent hippocampal evoked potentials using different perfusion solutions. SanMartín S; Menéndez L; Gutiérrez M; Hidalgo A; Baamonde A Acta Neurobiol Exp (Wars); 2000; 60(2):187-93. PubMed ID: 10909174 [TBL] [Abstract][Full Text] [Related]
37. Neuropeptide FF reverses the effect of mu-opioid on Ca2+ channels in rat spinal ganglion neurones. Rebeyrolles S; Zajac JM; Roumy M Neuroreport; 1996 Nov; 7(18):2979-81. PubMed ID: 9116223 [TBL] [Abstract][Full Text] [Related]
38. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a mu opioid. Chen L; Huang LY Neuron; 1991 Aug; 7(2):319-26. PubMed ID: 1678615 [TBL] [Abstract][Full Text] [Related]
39. [Effect of the enkephalin derivative DAGO on neuronal behavior and activity in the neocortex and hippocampus of rabbits during the acquisition of conditioned defense and inhibitory reflexes]. Shul'gina GI; Okhotnikov NV; Ryzhov SO; Cherdakova MV Zh Vyssh Nerv Deiat Im I P Pavlova; 1989; 39(2):309-19. PubMed ID: 2750293 [TBL] [Abstract][Full Text] [Related]
40. Development of acute tolerance during exposure of hippocampal explants to an opioid peptide. Gähwiler BH Brain Res; 1981 Jul; 217(1):196-200. PubMed ID: 6266591 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]